U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

The Centres for Medicare and Medicaid Services (CMS) said late on Friday that it would not cover anti-obesity medicines (AOMs) like Novo Nordisk's Wegovy (semaglutide) and Eli Lilly's Zepbound ...

Medicare’s block on obesity medication coverage can be traced back to a ... and Eli Lilly’s Zepbound (tirzepatide), which generally have to be paid for out-of-pocket as many private health ...

People who have tried other methods to lose weight have found results from obesity drugs that ‘feel like magic.’ ...

"Having said that, these weight-loss drugs (including Zepbound) are also good ... administration recently announced that Medicare and Medicaid would not cover the medications, as the Centers ...

Kennedy Jr. to keep a proposed Biden-era rule that would have allowed Medicare and Medicaid to cover drugs used to treat obesity after the Trump administration decided not to finalize it.

A pair of studies show that Zepbound can help adults with obesity and overweight achieve sustained and meaningful weight loss ...

AARP is a well-known company that offers supplemental health insurance for senior citizens looking to fill gaps in their Medicare coverage. The company offers eight Medicare plans through United ...